Loading the company…
Loading the company…
㈜한국바이오텍
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeongbuk, founded in 2010. Industry: R&D & Professional Services. Revenue for 2025 was ₩80.1bn. Workforce data is being verified. It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Patent list being verified. We show the counts together with the list once it is checked.
KIPO KIPRIS · checked 2026-10-15
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 5.1 | 80.1 |
| Operating expenses | 0.1 | 0.1 |
| Operating income (loss) | 5.0 | 80.0 |
| Non-operating income | 0.2 | 0.1 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.2 | 0.1 |
| Non-operating expenses | 0.0 | 8.4 |
| Other losses | 0.0 | 8.3 |
| Finance costs | — | 0.1 |
| Profit (loss) before tax | 5.2 | 71.7 |
| Income tax expense | 0.8 | 14.0 |
| Net income (loss) | 4.4 | 57.8 |
Revenue ₩80.1bn, up 1479.7% YoY.
Operating margin 99.9% (prior 98.8%).
Net income ₩57.8bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-05